• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小RNA-1-3p通过靶向细胞分裂调控蛋白1抑制肺腺癌细胞的肿瘤发生。

MiR-1-3p Inhibits Lung Adenocarcinoma Cell Tumorigenesis via Targeting Protein Regulator of Cytokinesis 1.

作者信息

Li Tao, Wang Xiuxiu, Jing Lijun, Li Yu

机构信息

Department of Respiratory Diseases, Qilu Hospital of Shandong University, Jinan, China.

出版信息

Front Oncol. 2019 Mar 1;9:120. doi: 10.3389/fonc.2019.00120. eCollection 2019.

DOI:10.3389/fonc.2019.00120
PMID:30881920
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6405482/
Abstract

Lung adenocarcinoma (LUAD) is one of the most lethal malignancies, posing a threat to human health. However, the molecular mechanisms underlying LUAD development remain largely unknown. In this study, we found that miR-1-3p was significantly downregulated in human LUAD tissues and cell lines and played an inhibitory role in LUAD cell tumorigenesis, as evidenced by the significantly reduced viability, migration, and invasion of LUAD cells in response to miR-1-3p overexpression. Mechanistically, microRNA (miR)-1-3p physically interacted with the 3'-untranslated region (UTR) of protein regulator of cytokinesis 1 (PRC1) mRNA, leading to downregulation of PRC1. Overexpression of PRC1 reversed the inhibitory effects of miR-1-3p on LUAD cell tumorigenesis, suggesting that the miR-1-3p/PRC1 axis is majorly involved in suppressing LUAD development and progression. Consistently, PRC1 was dramatically induced in LUAD tissues and cell lines as well as associated with a poor prognosis in LUAD patients. Taken together, our study identified the miR-1-3p/PRC1 axis as an important regulatory mechanism contributing to LUAD inhibition and provided valuable clues for the future development of therapeutic strategies against LUAD.

摘要

肺腺癌(LUAD)是最致命的恶性肿瘤之一,对人类健康构成威胁。然而,LUAD发生发展的分子机制仍 largely未知。在本研究中,我们发现miR-1-3p在人LUAD组织和细胞系中显著下调,并在LUAD细胞肿瘤发生中发挥抑制作用,miR-1-3p过表达导致LUAD细胞的活力、迁移和侵袭显著降低即证明了这一点。机制上,微小RNA(miR)-1-3p与胞质分裂1蛋白调节因子(PRC1)mRNA的3'-非翻译区(UTR)发生物理相互作用,导致PRC1下调。PRC1过表达逆转了miR-1-3p对LUAD细胞肿瘤发生的抑制作用,提示miR-1-3p/PRC1轴主要参与抑制LUAD的发生发展。同样,PRC1在LUAD组织和细胞系中显著诱导表达,并且与LUAD患者的不良预后相关。综上所述,我们的研究确定miR-1-3p/PRC1轴是促进LUAD抑制的重要调节机制,并为未来开发针对LUAD的治疗策略提供了有价值的线索。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8a7/6405482/3179d4bced2f/fonc-09-00120-g0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8a7/6405482/44afe209c987/fonc-09-00120-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8a7/6405482/dcd4830604f4/fonc-09-00120-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8a7/6405482/59cfb334ae57/fonc-09-00120-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8a7/6405482/824a8f2c21ac/fonc-09-00120-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8a7/6405482/69f1b461114f/fonc-09-00120-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8a7/6405482/2aece94ace8c/fonc-09-00120-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8a7/6405482/44919c9ca26e/fonc-09-00120-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8a7/6405482/68ba02c39ce9/fonc-09-00120-g0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8a7/6405482/3179d4bced2f/fonc-09-00120-g0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8a7/6405482/44afe209c987/fonc-09-00120-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8a7/6405482/dcd4830604f4/fonc-09-00120-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8a7/6405482/59cfb334ae57/fonc-09-00120-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8a7/6405482/824a8f2c21ac/fonc-09-00120-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8a7/6405482/69f1b461114f/fonc-09-00120-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8a7/6405482/2aece94ace8c/fonc-09-00120-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8a7/6405482/44919c9ca26e/fonc-09-00120-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8a7/6405482/68ba02c39ce9/fonc-09-00120-g0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8a7/6405482/3179d4bced2f/fonc-09-00120-g0009.jpg

相似文献

1
MiR-1-3p Inhibits Lung Adenocarcinoma Cell Tumorigenesis via Targeting Protein Regulator of Cytokinesis 1.微小RNA-1-3p通过靶向细胞分裂调控蛋白1抑制肺腺癌细胞的肿瘤发生。
Front Oncol. 2019 Mar 1;9:120. doi: 10.3389/fonc.2019.00120. eCollection 2019.
2
The LncRNA NEAT1 Accelerates Lung Adenocarcinoma Deterioration and Binds to Mir-193a-3p as a Competitive Endogenous RNA.长链非编码RNA NEAT1通过作为竞争性内源RNA与Mir-193a-3p结合来加速肺腺癌恶化。
Cell Physiol Biochem. 2018;48(3):905-918. doi: 10.1159/000491958. Epub 2018 Jul 23.
3
miR-373-3p promotes lung adenocarcinoma cell proliferation via APP.微小RNA-373-3p通过淀粉样前体蛋白促进肺腺癌细胞增殖。
Oncol Lett. 2018 Jan;15(1):1046-1050. doi: 10.3892/ol.2017.7372. Epub 2017 Nov 8.
4
LncRNA DGCR5 promotes lung adenocarcinoma (LUAD) progression via inhibiting hsa-mir-22-3p.长链非编码 RNA DGCR5 通过抑制 hsa-mir-22-3p 促进肺腺癌 (LUAD) 的进展。
J Cell Physiol. 2018 May;233(5):4126-4136. doi: 10.1002/jcp.26215. Epub 2017 Dec 18.
5
Downregulation of hsa-miR-30b-3p Inhibits the Oncogenicity of Lung Adenocarcinoma by Targeting the Gene.hsa-miR-30b-3p的下调通过靶向该基因抑制肺腺癌的致癌性。
J Oncol. 2022 May 20;2022:6883140. doi: 10.1155/2022/6883140. eCollection 2022.
6
miR-101-3p sensitizes lung adenocarcinoma cells to irradiation via targeting BIRC5.微小RNA-101-3p通过靶向凋亡抑制蛋白5使肺腺癌细胞对辐射敏感。
Oncol Lett. 2021 Apr;21(4):282. doi: 10.3892/ol.2021.12543. Epub 2021 Feb 10.
7
Long Noncoding RNA SBF2-AS1 Is Critical for Tumorigenesis of Early-Stage Lung Adenocarcinoma.长链非编码RNA SBF2-AS1对早期肺腺癌的肿瘤发生至关重要。
Mol Ther Nucleic Acids. 2019 Jun 7;16:543-553. doi: 10.1016/j.omtn.2019.04.004. Epub 2019 Apr 13.
8
CircRNA has_circ_0006427 suppresses the progression of lung adenocarcinoma by regulating miR-6783-3p/DKK1 axis and inactivating Wnt/β-catenin signaling pathway.环状 RNA 抑制肺腺癌的进展通过调节 miR-6783-3p/DKK1 轴和失活 Wnt/β-连环蛋白信号通路。
Biochem Biophys Res Commun. 2019 Jan 1;508(1):37-45. doi: 10.1016/j.bbrc.2018.11.079. Epub 2018 Nov 20.
9
MiR-202-3p inhibits the proliferation and metastasis of lung adenocarcinoma cells by targeting RRM2.微小RNA-202-3p通过靶向核糖核苷酸还原酶M2亚基抑制肺腺癌细胞的增殖和转移。
Ann Transl Med. 2022 Dec;10(24):1374. doi: 10.21037/atm-22-6089.
10
Prognostic Value of lncRNA DRAIC and miR-3940-3p in Lung Adenocarcinoma and Their Effect on Lung Adenocarcinoma Cell Progression.lncRNA DRAIC和miR-3940-3p在肺腺癌中的预后价值及其对肺腺癌细胞进展的影响
Cancer Manag Res. 2021 Nov 5;13:8367-8376. doi: 10.2147/CMAR.S320616. eCollection 2021.

引用本文的文献

1
Association between SOX gene family expression, DNA methylation, and miRNA regulation in lung adenocarcinoma progression.肺腺癌进展过程中SOX基因家族表达、DNA甲基化与miRNA调控之间的关联
Discov Oncol. 2025 Feb 15;16(1):188. doi: 10.1007/s12672-025-01892-x.
2
Intervening Non-Small-Cell Lung Cancer Progression by Cell Membrane Coated Platycodin D via Regulating Hsa-miR-1246/FUT9/GSK3β Pathway.通过细胞膜包裹的桔梗皂苷D调控Hsa-miR-1246/FUT9/GSK3β信号通路干预非小细胞肺癌进展
Int J Nanomedicine. 2025 Feb 6;20:1661-1678. doi: 10.2147/IJN.S479675. eCollection 2025.
3
The Oncogenic Role of , a Long Non-Coding RNA, in Epstein-Barr Virus-Associated Oral Squamous Cell Carcinoma: An Integrative Transcriptome and Functional Analysis.

本文引用的文献

1
The putative tumour suppressor miR-1-3p modulates prostate cancer cell aggressiveness by repressing E2F5 and PFTK1.拟肿瘤抑制因子 miR-1-3p 通过抑制 E2F5 和 PFTK1 来调节前列腺癌细胞的侵袭性。
J Exp Clin Cancer Res. 2018 Sep 5;37(1):219. doi: 10.1186/s13046-018-0895-z.
2
SPP1 and AGER as potential prognostic biomarkers for lung adenocarcinoma.SPP1和AGER作为肺腺癌潜在的预后生物标志物。
Oncol Lett. 2018 May;15(5):7028-7036. doi: 10.3892/ol.2018.8235. Epub 2018 Mar 12.
3
miR‑1 inhibits the progression of colon cancer by regulating the expression of vascular endothelial growth factor.
长链非编码RNA 在爱泼斯坦-巴尔病毒相关口腔鳞状细胞癌中的致癌作用:综合转录组学与功能分析
Int J Mol Sci. 2024 Nov 22;25(23):12565. doi: 10.3390/ijms252312565.
4
microRNA-1 Regulates Metabolic Flexibility in Skeletal Muscle via Pyruvate Metabolism.微小RNA-1通过丙酮酸代谢调节骨骼肌的代谢灵活性。
bioRxiv. 2024 Aug 10:2024.08.09.607377. doi: 10.1101/2024.08.09.607377.
5
In silico identification and in vitro evaluation of MRPS30-DT lncRNA and MRPS30 gene expression in breast cancer.基于计算的方法鉴定和体外评估乳腺癌中 MRPS30-DT lncRNA 和 MRPS30 基因的表达。
Cancer Rep (Hoboken). 2024 Jun;7(6):e2114. doi: 10.1002/cnr2.2114.
6
Transcriptomic analysis revealed potential regulatory biomarkers and repurposable drugs for breast cancer treatment.转录组分析揭示了潜在的乳腺癌治疗调控生物标志物和可再利用药物。
Cancer Rep (Hoboken). 2024 May;7(5):e2009. doi: 10.1002/cnr2.2009.
7
MicroRNA‑mediated regulation in lung adenocarcinoma: Signaling pathways and potential therapeutic implications (Review).微小 RNA 在肺腺癌中的调控作用:信号通路与潜在治疗意义(综述)。
Oncol Rep. 2023 Dec;50(6). doi: 10.3892/or.2023.8648. Epub 2023 Oct 20.
8
Identify miRNA-mRNA regulation pairs to explore potential pathogenesis of lung adenocarcinoma.鉴定 miRNA-mRNA 调控对,探索肺腺癌潜在发病机制。
Aging (Albany NY). 2022 Oct 19;14(20):8357-8373. doi: 10.18632/aging.204341.
9
Icariin attenuates the tumor growth by targeting miR-1-3p/TNKS2/Wnt/β-catenin signaling axis in ovarian cancer.淫羊藿苷通过靶向miR-1-3p/TNKS2/Wnt/β-连环蛋白信号轴抑制卵巢癌肿瘤生长。
Front Oncol. 2022 Sep 14;12:940926. doi: 10.3389/fonc.2022.940926. eCollection 2022.
10
Identification of Ferroptosis-Related Hub Genes and Their Association with Immune Infiltration in Chronic Obstructive Pulmonary Disease by Bioinformatics Analysis.基于生物信息学分析鉴定慢性阻塞性肺疾病中与铁死亡相关的枢纽基因及其与免疫浸润的关系。
Int J Chron Obstruct Pulmon Dis. 2022 May 24;17:1219-1236. doi: 10.2147/COPD.S348569. eCollection 2022.
miR-1 通过调节血管内皮生长因子的表达抑制结肠癌的进展。
Oncol Rep. 2018 Aug;40(2):589-598. doi: 10.3892/or.2018.6463. Epub 2018 May 24.
4
miR-1-3p and miR-206 sensitizes HGF-induced gefitinib-resistant human lung cancer cells through inhibition of c-Met signalling and EMT.miR-1-3p 和 miR-206 通过抑制 c-Met 信号和 EMT 使 HGF 诱导的吉非替尼耐药人肺癌细胞敏感。
J Cell Mol Med. 2018 Jul;22(7):3526-3536. doi: 10.1111/jcmm.13629. Epub 2018 Apr 17.
5
The microtubule-associated protein PRC1 is a potential therapeutic target for lung cancer.微管相关蛋白PRC1是肺癌的一个潜在治疗靶点。
Oncotarget. 2017 Dec 22;9(4):4985-4997. doi: 10.18632/oncotarget.23577. eCollection 2018 Jan 12.
6
MiR-1-3p inhibits cell proliferation and invasion by regulating BDNF-TrkB signaling pathway in bladder cancer.miR-1-3p 通过调控脑源性神经营养因子-TrkB 信号通路抑制膀胱癌细胞的增殖和侵袭。
Neoplasma. 2018;65(1):89-96. doi: 10.4149/neo_2018_161128N594.
7
PRC1 contributes to tumorigenesis of lung adenocarcinoma in association with the Wnt/β-catenin signaling pathway.PRC1 与 Wnt/β-catenin 信号通路相关,有助于肺腺癌的肿瘤发生。
Mol Cancer. 2017 Jun 24;16(1):108. doi: 10.1186/s12943-017-0682-z.
8
ADAM9 enhances CDCP1 by inhibiting miR-1 through EGFR signaling activation in lung cancer metastasis.ADAM9通过激活EGFR信号通路抑制miR-1,从而增强CDCP1,促进肺癌转移。
Oncotarget. 2017 Jul 18;8(29):47365-47378. doi: 10.18632/oncotarget.17648.
9
MicroRNA-1 overexpression blunts cardiomyocyte hypertrophy elicited by thyroid hormone.miRNA-1 过表达可减轻甲状腺激素引起的心肌细胞肥大。
J Cell Physiol. 2017 Dec;232(12):3360-3368. doi: 10.1002/jcp.25781. Epub 2017 Mar 28.
10
Cancer Statistics, 2017.《2017 年癌症统计》
CA Cancer J Clin. 2017 Jan;67(1):7-30. doi: 10.3322/caac.21387. Epub 2017 Jan 5.